Company filings profile · CIK 0001716166
Vivos Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Vivos Therapeutics, Inc. (VVOS): 18 filings in the last 90 days vs 15 in the prior 90 (filing-velocity rising ↑ · 1.2×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 1, 2026. Source-linked, daily-refreshed.
Material 8-K events — Vivos Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 1, 2026 | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 21, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 11, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jul 7, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jun 25, 2026 | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 16, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 16, 2026 | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 8, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Delisting / Listing-Rule Failure; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 22, 2026 | Delisting / Listing-Rule Failure | ↗ |
| Apr 15, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 3, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
Watch Vivos Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 1, 2026 | 8-K | Change in Auditor; Financial Statements and Exhibits | ↗ |
| Sep 18, 2026 | 4 | 4 | ↗ |
| Sep 18, 2026 | 4 | 4 | ↗ |
| Sep 18, 2026 | 4 | 4 | ↗ |
| Sep 8, 2026 | 8-K/A | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Sep 3, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 26, 2026 | 4 | 4 | ↗ |
| Aug 21, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | 10-Q | 10-Q | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 11, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 11, 2026 | SCHEDULE 13G | ↗ | |
| Aug 3, 2026 | 8-K | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | SCHEDULE 13D | ↗ | |
| Jul 15, 2026 | 4 | 4 | ↗ |
| Jul 15, 2026 | 3 | 3 | ↗ |
| Jul 7, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jun 25, 2026 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 16, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jun 16, 2026 | 8-K | Entry into a Material Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 8, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Delisting / Listing-Rule Failure; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 20, 2026 | 10-Q | 10-Q | ↗ |
| May 15, 2026 | NT 10-Q | NT 10-Q | ↗ |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 8, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 8, 2026 | 424B3 | 424B3 | ↗ |
| May 6, 2026 | CORRESP | ↗ | |
| Apr 30, 2026 | S-3/A | S-3/A | ↗ |
| Apr 22, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Apr 15, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 15, 2026 | 10-K | 10-K | ↗ |
| Apr 10, 2026 | 3 | 3 | ↗ |
| Apr 3, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | 4 | 4 | ↗ |
| Apr 2, 2026 | SCHEDULE 13D | ↗ | |
| Mar 31, 2026 | NT 10-K | NT 10-K | ↗ |
| Feb 23, 2026 | UPLOAD | ↗ | |
| Feb 17, 2026 | S-3 | S-3 | ↗ |
| Feb 13, 2026 | 3 | 3 | ↗ |